Lansoprazole
Product Images NDC 33261-674

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 33261-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lansoprazole Dr 30mg Cap For Dr Reddy 1)

Chemical structure of Lansoprazole, showing its molecular framework including a benzimidazole ring, a sulfoxide group, and a substituted pyridine ring with trifluoromethoxy substitution.*

FDA Label Image

Figure1 (Lansoprazole Dr 30mg Cap For Dr Reddy 2)

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' comparing the severity of heartburn over time among placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD groups. The y-axis measures mean severity on a scale from 0 (none) to 3 (severe), and the x-axis represents days from the start of treatment, ranging from -5 to 60 days. The graph shows decreasing heartburn severity in the Lansoprazole groups compared to placebo over the treatment period.*

FDA Label Image

Figure2 (Lansoprazole Dr 30mg Cap For Dr Reddy 3)

A line graph showing mean severity of night heartburn over days from start of treatment for patients receiving placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. Severity is rated from 0 (none) to 3 (severe). The graph depicts severity declining over approximately 60 days.*

FDA Label Image

Image Label (Lansoprazole Dr 30mg Cap For Dr Reddy 4)

Label for Lansoprazole DR 30 mg capsules, 30 count, distributed by Aidarex Pharmaceuticals LLC. The label states the capsules are pink and black oblong with RDY 399 on one side and contain 30 mg of delayed-release lansoprazole. It includes the NDC 33261-0674-30 and notes generic for Prevacid. Manufacturer is Dr. Reddy's Laboratories Limited, Bachepalli, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.